Thursday, September 8, 2016

Monteris Medical wins FDA IDE nod for another Neurablate brain cancer trial

Monteris Medical said today it won FDA investigational device exemption to explore the use of its NeuroBlate system in patients newly diagnosed with glioblastoma multiforme.
The NeuroBlate system is designed to ablate, necrotize or coagulate soft tissue …

No comments:

Post a Comment